Kayne Anderson Rudnick Investment Management LLC Increases Stock Position in National Research Co. (NASDAQ:NRC)

Kayne Anderson Rudnick Investment Management LLC boosted its holdings in National Research Co. (NASDAQ:NRC) by 0.6% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,045,306 shares of the company’s stock after acquiring an additional 18,891 shares during the quarter. Kayne Anderson Rudnick Investment Management LLC owned 12.75% of National Research worth $69,890,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in the business. Precision Wealth Strategies LLC boosted its position in shares of National Research by 7.9% during the first quarter. Precision Wealth Strategies LLC now owns 5,623 shares of the company’s stock valued at $223,000 after buying an additional 413 shares during the last quarter. Russell Investments Group Ltd. boosted its holdings in shares of National Research by 6.3% during the 1st quarter. Russell Investments Group Ltd. now owns 14,348 shares of the company’s stock valued at $568,000 after acquiring an additional 847 shares during the last quarter. Rhumbline Advisers grew its stake in shares of National Research by 4.3% in the second quarter. Rhumbline Advisers now owns 21,453 shares of the company’s stock worth $492,000 after acquiring an additional 892 shares during the period. Benjamin F. Edwards & Company Inc. lifted its position in National Research by 860.2% during the first quarter. Benjamin F. Edwards & Company Inc. now owns 1,133 shares of the company’s stock valued at $45,000 after purchasing an additional 1,015 shares during the period. Finally, CWM LLC boosted its holdings in National Research by 889.7% in the second quarter. CWM LLC now owns 1,158 shares of the company’s stock worth $27,000 after purchasing an additional 1,041 shares during the last quarter. 47.26% of the stock is currently owned by hedge funds and other institutional investors.

National Research Trading Down 1.4 %

NASDAQ:NRC opened at $21.64 on Friday. The company has a 50 day simple moving average of $22.59 and a two-hundred day simple moving average of $28.49. The company has a market cap of $516.70 million, a PE ratio of 17.45 and a beta of 0.48. The company has a current ratio of 0.37, a quick ratio of 0.37 and a debt-to-equity ratio of 0.64. National Research Co. has a 12 month low of $20.41 and a 12 month high of $47.25.

National Research (NASDAQ:NRC) last posted its quarterly earnings data on Tuesday, August 6th. The company reported $0.26 EPS for the quarter. The company had revenue of $35.02 million during the quarter. National Research had a return on equity of 63.64% and a net margin of 20.01%.

National Research Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 11th. Investors of record on Friday, September 27th will be paid a dividend of $0.12 per share. The ex-dividend date of this dividend is Friday, September 27th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 2.22%. National Research’s dividend payout ratio (DPR) is presently 38.71%.

National Research Profile

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.